Corporate Governance

Please find below the essential documentation on our corporate governance.

  • Bezugsrechtskapitalerhöhung 2026

    • Informationsdokument nach Anhang IX der EU-Prospektverordnung: (English)

    • Bezugsangebot (German)

  • Rules of Procedure of the Supervisory Board (English / German)

  • Declaration of Conformity

    • Current Declaration of Conformity, dated December 17, 2025: (English / German)

    • Declaration of Conformity, dated December 20, 2024: (English / German)

    • Declaration of Conformity, dated October 29, 2024: (English / German)

    • Declaration of Conformity, dated September 23, 2024: (English/ German)

  • Corporate Governance Statement and Report (only German)

  • Vergütungsbericht 2025 (only German)

  • Articles of Association of Pentixapharm Holding AG (PDF)

  • Prospectus for Public Offering – Dated September 23, 2024 (PDF)

Auditor

MSW GmbH Wirtschaftsprüfungsgesellschaft Steuerberatungsgesellschaft, Berlin, has been the auditor of the Annual Financial Statements and of the Consolidated Financial Statements for the 2025 financial year.

← Back to Investor Center